|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-6-20
|
|
pubmed:abstractText |
Enhanced susceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTI) was recently described in association with increased resistance to nucleoside analogs (nucleoside reverse transcriptase inhibitors; NRTI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1125-32
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11416714-Anti-HIV Agents,
pubmed-meshheading:11416714-Benzoxazines,
pubmed-meshheading:11416714-Cohort Studies,
pubmed-meshheading:11416714-Drug Resistance, Microbial,
pubmed-meshheading:11416714-HIV Infections,
pubmed-meshheading:11416714-HIV-1,
pubmed-meshheading:11416714-Humans,
pubmed-meshheading:11416714-Mutagenesis,
pubmed-meshheading:11416714-Nucleosides,
pubmed-meshheading:11416714-Oxazines,
pubmed-meshheading:11416714-Phenotype,
pubmed-meshheading:11416714-Retrospective Studies,
pubmed-meshheading:11416714-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy.
|
|
pubmed:affiliation |
Stanford University School of Medicine, Stanford, CA 94305, USA.
|
|
pubmed:publicationType |
Journal Article
|
